SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is surging following a strong quarterly report that exceeded revenue and earnings expectations, primarily driven by accelerated growth in its Azure cloud business. The community is actively discussing the company's ability to maintain high AI capital expenditures while managing free cash flow, a contrast to recent performance from other tech giants that has fueled a broader market rebound.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group N.V. (NBIS) is currently experiencing high volatility and significant downward pressure as market participants debate whether recent price action is driven by sector-wide hedge fund margin calls or broader concerns over AI capital expenditure sustainability. The community remains deeply divided, with some investors aggressively buying what they perceive as a long-term discount, while others warn of further technical breakdowns and are calling for caution until the stock establishes a stable base.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is experiencing significant investor enthusiasm driven by strong operational performance and upward revisions in guidance, with the community closely tracking its momentum in both defense contracts and its SMR nuclear power division. Sentiment remains heavily bullish as shareholders point to a successful corporate transformation and potential market leadership in next-generation propulsion systems.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad regulatory approval of its immunotherapy drug ANKTIVA for bladder and lung cancer, which has ignited community discussions about global expansion and the potential for a short squeeze. Investors are now closely watching for upcoming earnings and potential partnership announcements, with the community actively debating the stock's long-term commercial prospects against persistent short-selling pressure.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing heavy downward pressure as investors react to a significant earnings miss and concerns over aggressive capital expenditure on AI infrastructure that has severely impacted free cash flow. While some in the community highlight the company's strong ad revenue growth, others are actively debating whether the current pullback represents a buying opportunity or the beginning of a deeper structural decline.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is currently a central focus for market participants following a significant earnings beat and raised guidance that highlighted strong operational execution despite macroeconomic headwinds. The community is actively debating the company's long-term growth potential and its ability to maintain its AI-driven flywheel against broader fintech sector volatility, with many users pointing to consistent ABS issuance and insider confidence as key indicators of undervaluation.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is currently a major focus for investors as the market monitors AWS cloud revenue growth and aggressive capital expenditure on AI infrastructure ahead of earnings. Community discussion is heavily polarized, with many debating if the stock's recent volatility is a prime buying opportunity for long-term cloud and AI growth or a sign of deeper structural issues.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as investors weigh resilient AI sector earnings and corporate capex guidance against broader concerns regarding rising long-term Treasury yields and geopolitical tensions. Community sentiment is deeply divided, with traders intensely debating whether the recent price action represents a sustainable bottom or merely a bear market trap.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is facing intense downward pressure driven by a combination of broader semiconductor sector volatility, concerns over handset demand, and skepticism regarding near-term margin health despite a series of bullish price target cuts. The community remains deeply divided, with bulls pointing to the company's long-term AI diversification and automotive growth as a contrarian opportunity, while bears argue that the stock is caught in a persistent cycle of margin dilution and execution risk.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is currently the subject of intense community debate following the filing of a $500 million at-the-market (ATM) shelf offering, with investors split between viewing it as a prudent move for long-term financial flexibility and a precursor to near-term dilution. The conversation is further fueled by anticipation for upcoming maintenance dosing data, which many hope will act as a pivotal catalyst to solidify the company's competitive position in the obesity market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


23wincomart

Nhà Cái 23WIN